Pain Therapeutics reported $204.2M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 32M 10.81M
Amgen AMGN:US $ 19322M 802M
Biogen BIIB:US $ 9740.9M 1825M
Cara Therapeutics CARA:US $ 176.17M 24.4M
Eisai 4523:JP Y 620947M 19659M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Geron GERN:US $ 227.38M 51.45M
Novartis NOVN:VX 38.14B 906M
Novavax NVAX:US $ 2136M 211.4M
Pain Therapeutics PTIE:US $ 204.2M 18M